Limitations, agreements, and source contact

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib · Source last updated 2018-09-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Early termination after enrollment held for toxicity evaluation; then closed due to competing trial.

point Of Contact

email

sfenness@bu.edu

organization

Boston Medical Center

phone

6176388261

title

Vaishali Sanchorawala, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice